Who founded Delineate?

Delineate was founded by Emily Nieves, Jawad Iqbal in 2024.

Who are Delineate's investors?

Delineate's investors include Civilization Ventures Management, Llc, Y Combinator, Cannage Capital, Capitoria, Peak XV Partners, Unpopular Ventures.

Where is Delineate headquartered?

Delineate is headquartered in Boston, US.

Delineate

YC W25

Boston, US · Founded 2024 · 20 employees · 6 known investors

Find your way into Delineate

Paths you didn't know you had: your email and LinkedIn already hold routes to the Delineate team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.

AI & Machine Learning Biotech Developer Tools Enterprise Software SaaS AIUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (W25)

Delineate was founded in 2024 by Emily Nieves and Jawad Iqbal.

Emily Nieves Co-Founder & CEOShe completed doctoral studies in biological engineering at MIT and previously worked as a scientist at Pfizer and AstraZeneca, where she developed AI methods for drug modeling and simulation.

Jawad Iqbal Co-Founder @ Delineate | YC-W25Jawad Iqbal holds a master's degree in robotics and AI with published research, and previously worked as a technical project manager on digital transformation initiatives within Lockheed Martin's advanced development division.

Jawad Iqbal Co-Founder @ Delineate | YC-W25

Investors · 6

Civilization Ventures Management, Llclisted by Civilization Ventures Management, LlcTiburon · $1M – $10M

How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Cannage CapitalreportedLas Vegas

How we know: Y Combinator's founder network · Not right? Tell us

Capitoriareported

How we know: Y Combinator's founder network · Not right? Tell us

Peak XV PartnersreportedBengaluru · $100K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Intact TherapeuticsIntact Therapeutics develops next-generation biopharmaceutical therapies for gastrointestinal diseases to address unmet clinical needs. The company is clinical-stage and focused on improving patient outcomes through innovative medicines.

Encepheal TherapeuticsEncepHeal develops small-molecule medications targeting the dopamine transporter to treat stimulant addiction, including cocaine and methamphetamine, for which no FDA-approved treatments currently exist. The company uses allosteric modulators designed to reduce drug cravings without the addictive potential of earlier dopamine-targeting approaches.

CurebaseCurebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites. The platform emphasizes modern technology, data integrity, and compliance for advancing medical research.

Mark Cuban Cost Plus Drug Company, PBCMark Cuban Cost Plus Drug Company manufactures affordable generic medications, offering lower-priced alternatives to existing pharmaceutical products.

10x Science10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.

Companies working in the same space as Delineate.

Legal entities · 1

corporate structure

Delineate Inc.

In the news

Delineate - Information Overload to Insights in Biopharmaycombinator.com · Feb 2025

Frequently asked questions

What does Delineate do?: Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.
Who founded Delineate?: Delineate was founded by Emily Nieves, Jawad Iqbal in 2024.
Who are Delineate's investors?: Delineate's investors include Civilization Ventures Management, Llc, Y Combinator, Cannage Capital, Capitoria, Peak XV Partners, Unpopular Ventures.
Where is Delineate headquartered?: Delineate is headquartered in Boston, US.